Alameda Healthcare Group (Alameda), Egypt’s leading private healthcare service provider, announces recently the signing of an MoU with Varian – a Siemens Healthineers company.
Industry sources added that this MoU will witness the establishment of an Alameda site as a reference center for Varian products in the Middle East and Africa, facilitating knowledge transfer for clinical staff from various hospitals, both within and outside Egypt.
Industry sources added that the signing event took place at Varian’s headquarters in Palo Alto, USA, bringing together distinguished representatives from both Alameda and Varian. Notable attendees included Dr. Fahad Khater, Chairman of Alameda Healthcare, Mr. Neeraj Mishra, Group CEO of Alameda Healthcare, Laurent Amiel, President of Radiation Oncology Solutions EMEA, and Ashok Kakkar, Vice President and Zone Head of Radiation Oncology Solutions MEA, representing Varian as well as Eng. Ahmed Shanan, CEO of IEC Medical Systems, Varian’s designated business partner in Egypt.
Commenting on the partnership, Dr. Fahad Khater, Chairman of Alameda Healthcare Group stated “Our collaboration with Varian stands as a resounding testament to our commitment to elevating the standard of healthcare in Egypt. Through this partnership, Alameda seizes a unique opportunity to revolutionize cancer care in the country through cutting-edge technology, ultimately resulting in improved patient outcomes and a healthier population. This alliance marks a significant stride toward realizing our vision of a healthcare industry that sets new standards for excellence across Egypt and beyond.”
Laurent Amiel, President of Radiation Oncology Solution in Europe, the Middle East, and Africa at Varian also commented stating, “Varian is committed to enhancing care experience for both patients and clinicians and expanding access to high-quality treatment. We are proud to join forces with Alameda Healthcare Group to advance this important goal throughout Egypt, the Middle East, and Africa.”
Mr. Amiel stated further “This collaboration marks a significant step forward in our shared dedication to elevate cancer care, driven by innovations, education, and a shared vision of healthcare excellence. Together, we aim to improve the realm of cancer care, making a positive impact on countless individuals’ lives in these regions and beyond.”
Industry sources further added that the partnership between Alameda and Varian marks a pivotal moment in the evolution of healthcare in Egypt, the remaining Middle East, and the broader African region. With the establishment of an Alameda reference center for Varian products, the development of cutting-edge medical technologies, and a shared dedication to improving patient outcomes, this collaboration embodies a profound commitment to healthcare excellence.